Valentim, Carolina C. S.
Wu, Anna K.
Yu, Sophia
Manivannan, Niranchana
Zhang, Qinqin
Cao, Jessica
Song, Weilin
Wang, Victoria
Kang, Hannah
Kalur, Aneesha
Iyer, Amogh I.
Conti, Thais
Singh, Rishi P.
Talcott, Katherine E.
Article History
Received: 30 September 2023
Accepted: 4 January 2024
First Online: 23 January 2024
Declarations
:
: This cross-sectional study was approved by the Cleveland Clinic Institutional Review Board and informed consent was waived due to its observational nature.
: Not applicable.
: SY and NM report employment for Carl Zeiss Meditec, Inc. RPS reports personal fees from Genentech/Roche, Alcon, Novartis, Regeneron, Asclepix, Gyroscope, Bausch and Lomb, and Apellis. KET reports personal fees from Genentech/Roche, Apellis, Alimera, Iveric Bio, Bausch and Lomb, and EyePoint; research fees from Zeiss and Regenxbio. All other authors do not report any disclosures.